Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: OTC US
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Services
  • Sub-Industry: Medical-Hospitals

Avita Medical Ltd

+ Add to Watchlist

AVMXF:US

0.1250 USD 0.00000.00%

As of 20:10:00 ET on 05/23/2013.

Company Profile for Avita Medical Ltd (AVMXF)

Avita Medical Limited is a biotechnology company which develops and distributes tissue-engineered cellular products for skin replacement. The Company's products include CellSpray and ReCell, which are used for the treatment of burns and other skin injuries, previous scarring, chronic wounds and cosmetic procedures.

Contact Information

Avita Medical Ltd

Level 9, The Quadrant
1 William Street
Perth, WA 6001
Australia
Phone: 61-8-9355-6288
Fax: 61-8-9470-6388

Key Executives for Avita Medical Ltd (AVMXF)

William Ford DolphinCEO/Managing DirectorTimothy Rooney "Tim"CFO/COO
William MarshallVP:OperationsAndrew QuickVP:Research & Technology
Lorraine GloverGeneral Manager:Asia PacificGabriel ChiappiniSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil